Trademark: 79337738
Status Date
Wednesday, July 12, 2023
Filing Date
Wednesday, January 19, 2022
5 Pharmaceutical preparations for the treatment and prevention of cancer, oncological diseases, leukemia, musculoskeletal disorders, muscular dystrophy, pseudoxanthoma, dermatological disorders, allergy, cardiovascular diseases, kidney diseases, fibrodysplasia ossificans progressiva; vaccines for human use
The mark consists of a design of two semi-circles with the top composed of four overlapping curved lines with the background lines in purple and light yellow and the foreground lines in navy blue and dark yellow with the lower semi-circle being in the same colors upside-down all within a navy blue circle. The color white represents background or transparent areas only and is not claimed as a feature of the mark.
The color(s) navy blue, purple, and yellow is/are claimed as a feature of the mark.
Oct 3, 2023
Notification Of Possible Opposition - Processed By Ib
Sep 13, 2023
Notification Of Possible Opposition Sent To Ib
Sep 13, 2023
Notification Of Possible Opposition Created, To Be Sent To Ib
Jul 12, 2023
Teas/Email Correspondence Entered
Jul 12, 2023
Correspondence Received In Law Office
Jul 12, 2023
Teas Response To Office Action Received
Feb 7, 2023
Refusal Processed By Ib
Jan 13, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Jan 13, 2023
Refusal Processed By Mpu
Nov 2, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Nov 1, 2022
Non-Final Action Written
Oct 28, 2022
Assigned To Examiner
Jul 3, 2022
New Representative At Ib Received
Jun 4, 2022
New Representative At Ib Received
Apr 26, 2022
Application Filing Receipt Mailed
Apr 21, 2022
New Application Office Supplied Data Entered
Apr 15, 2022
Limitation From Original Application Entered
Apr 7, 2022
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
